KPS

Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients

Retrieved on: 
Tuesday, May 10, 2022
Neuroscience, Information technology, KPS, GLOBE, Food, Depression, Patient, Trial of the century, Partnership, Acute myeloid leukemia, FDA, Cancer, Therapy, Anxiety, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Attune, Adult, PDT, Blue Note Records, CEO, Harold Melvin & the Blue Notes, Grammatical mood, Research, SAN, Growth, Dreamland, Pharmaceutical industry

The agreement includes attuneTM and DreAMLandTM, Blue Note's lead PDTs designed to support the mental well-being of patients living with cancer.

Key Points: 
  • The agreement includes attuneTM and DreAMLandTM, Blue Note's lead PDTs designed to support the mental well-being of patients living with cancer.
  • "It is encouraging to introduce digital therapeutics that can specifically treat the anxiety and depressive symptoms of patients with cancer in Korea through this partnership with Blue Note Therapeutics," said Mikyoung Hahn, CEO of Bixink.
  • "Our mission is to ease the burden of cancer and improve outcomes for all patients," said Geoffrey Eich, CEO of Blue Note Therapeutics.
  • Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to serving patients suffering from cancer.

Strategic Biofuels and Koch Project Solutions Agree on EPC Guarantee for Louisiana Green Fuels Project

Retrieved on: 
Thursday, April 21, 2022
Oil, Gas, Chemicals, Plastics, Coal, Alternative Energy, Energy, Manufacturing, Nuclear, Other Natural Resources, Environment, Forest Products, Agriculture, Natural Resources, Other Manufacturing, Other Energy, Utilities, Engineering, Carbon, Well, Koch, CCS, Forest, EPC, Forestry, Project management, Lump sum turnkey, KPS, La Porte, British Columbia, Engineering, Port, Solution, LGF, FEED, Carbon credit, Safety, Partnership, Industry, Renewable energy

Strategic Biofuels , the leader in developing deeply negative carbon footprint renewable fuels plants, announced today that it has finalized its partnership with leading engineering, procurement and construction (EPC) firm, Koch Project Solutions (KPS) a subsidiary of Koch Engineered Solutions, for their Louisiana Green Fuels (LGF) Project in Caldwell Parish, Louisiana.

Key Points: 
  • Strategic Biofuels , the leader in developing deeply negative carbon footprint renewable fuels plants, announced today that it has finalized its partnership with leading engineering, procurement and construction (EPC) firm, Koch Project Solutions (KPS) a subsidiary of Koch Engineered Solutions, for their Louisiana Green Fuels (LGF) Project in Caldwell Parish, Louisiana.
  • Koch Project Solutions is excited to continue our work with Strategic Biofuels, said Antoine Schellinger, senior vice president of corporate development for Koch Project Solutions.
  • Louisiana Green Fuels is the first project by Strategic Biofuels LLC in Northern Louisiana at the Port of Columbia in Caldwell Parish.
  • Koch Project Solutions is a part of Koch Engineered Solutions providing world-class services and technologies broadly across industrial sectors.

ReGen III: Announces Appointment of Vice President, Corporate Finance

Retrieved on: 
Tuesday, April 19, 2022
Export Development Canada, LLC, Recycling, Commerce, Virtual College of Biotechnology, University of Saskatchewan, Research, Economics, CPA, KPS, III Corps (United States), Regen, Bachelor of Commerce, BP, FSE, Corporate finance, Company, Solution, Cannabis, CMA, Canada, University, Pharmaceutical industry, Construction, Security (finance)

Vancouver, British Columbia--(Newsfile Corp. - April 19, 2022) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company") is pleased to announce the appointment of Kimberly Hedlin as Vice President, Corporate Finance of the Company, effective immediately.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - April 19, 2022) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company") is pleased to announce the appointment of Kimberly Hedlin as Vice President, Corporate Finance of the Company, effective immediately.
  • Since 2020, Ms. Hedlin has been supporting companies, including ReGen III, as an independent consultant offering a broad platform of services including corporate communications, investor relations, market research, financial modeling and analysis, and project management.
  • "We are thrilled to have Kim join the ReGen III team.
  • In connection with Ms. Hedlin's appointment, the Company issued 200,000 stock options at an exercise price of $1.64 per option.

ReGen III: Update

Retrieved on: 
Saturday, April 9, 2022
Company, GHD, FSE, Economics, Mission statement, Independent Engineer, Contract, Investment, Regen, Climate change, Transport, Recycling, Person, Blue Deer school, Risk management, KPS, CDN, Extended play, Carbon, Greenhouse gas, Share (finance), Prospectus, LLC, Equator Principles, EP4, Review, Architecture, BP, GHG, EDC, Solution, News, III Corps (United States), Risk assessment, Biophysical environment, Export Development Canada, Security (finance), Construction, Oil, Category, Oiltanking

The subscribers consisted primarily of existing shareholders initially introduced to ReGen III, by Blue Deer Capital Partners Inc. ("Blue Deer").

Key Points: 
  • The subscribers consisted primarily of existing shareholders initially introduced to ReGen III, by Blue Deer Capital Partners Inc. ("Blue Deer").
  • ReGen III intends to use the net proceeds of the Offering for project engineering, due diligence expenses, working capital and general corporate purposes.
  • In addition, EDC selected an independent market advisor and is working alongside ReGen III to complete the contractual engagement process.
  • For more information on ReGen III or to subscribe to the Company's mailing list, please visit: www.regeniii.com/investors/corporate-presentations and www.regeniii.com/newsletter-subscription .

Primient Launches as a Leading Producer of Food and Industrial Products Made From Plant-Based, Renewable Sources

Retrieved on: 
Monday, April 4, 2022
American depositary receipt, Tate & Lyle, LinkedIn, Organization, Investment, Health, Snack, Informal economy, Tate, London, Paper, KPS, Drink, Science, Entrepreneurship, London Stock Exchange, KPS Capital Partners, Twitter, Taste, Partner, Solution, Fine chemical, Renewable energy, LP, Food

CHICAGO, April 4, 2022 /PRNewswire-PRWeb/ --Primient enters the global food and industrial ingredients market with a strong portfolio of proven products and trusted application expertise across the food, beverage, paper, packaging, personal care, apparel, and animal nutrition industries.

Key Points: 
  • Primient employs more than 1,500 colleagues and operates six industrial plants in North America and Latin America and has an interest in two joint ventures.
  • The company has a proud legacy in agricultural entrepreneurship grounded in the ingenuity of agriculture pioneer and legend, A.E.
  • Primient is now poised for success as a leading, independent, and focused manufacturer of critical corn-derived ingredients for both food and industrial markets.
  • Primient is a leading producer of food and industrial ingredients made from plant-based, renewable sources.

ReGen III: Texas Project Update

Retrieved on: 
Wednesday, March 23, 2022
Company, Akin Gump Strauss Hauer & Feld, FSE, Economics, Independent Engineer, Contract, Investment, Regen, Board, Recycling, KMPS, KPS, Atmosphere, CEO, PDP, Oiltanking, LLC, Intention, BP, EDC, Solution, III Corps (United States), HAZOP, Engineering, Export Development Canada, Real estate, Risk management, Renewable energy, Construction

ReGen III's finance team met with its tax advisors, Grant Thornton LLP, to determine the most efficient structure for the PE Firm's proposed investments at the Texas project level.

Key Points: 
  • ReGen III's finance team met with its tax advisors, Grant Thornton LLP, to determine the most efficient structure for the PE Firm's proposed investments at the Texas project level.
  • As a result of tax and legal advice received, ReGen III instructed its US counsel at Akin Gump Strauss Hauer & Feld LLP to establish two US subsidiaries: (1) the Texas project operations unit, RG3 Texas LLC; and (2) the investment holding unit, RG3 Texas Holdings LLC, where project level funding from ReGen III, the PE Firm and the debt providers will be contributed.
  • ReGen III is advancing our Texas recycling project with the PE Firm, EDC and KPS on an expedited basis.
  • ReGen III has already signed a definitive offtake agreement with bp to purchase 100% of the Company's base oils produced at the proposed Texas re-refining facility.

Planet Water Foundation's Project 24 Brings Clean Water to Thousands in Need

Retrieved on: 
Thursday, March 17, 2022
Columbia Sportswear, Virus, Marie-Françoise Matouk, Organization, Behavior, Caregiver, Bacteria, NortonLifeLock, Water planet, KPS, Hygiene, Health, CEO, School, Learning, Quality of life, World Water Day, Drinking water, Knowledge, GLOBE, Awareness, Water, Bottled water, Electrolux, Speedo

This year's event is projected to bring clean water to over 50,000beneficiaries living in impoverished communities and is made possible through the support of Planet Water Foundation's dedicated corporate partners.

Key Points: 
  • This year's event is projected to bring clean water to over 50,000beneficiaries living in impoverished communities and is made possible through the support of Planet Water Foundation's dedicated corporate partners.
  • In addition to clean drinking water, Planet Water Foundation's AquaTower projects also provide rural schools and communities with handwashing and sanitation infrastructure.
  • Planet Water Foundation is a non-profit organization focused on bringing clean water to the world's most impoverished communities through the installation of community-based water filtration systems and the deployment of hygiene education programs.
  • Since 2009, Planet Water has deployed more than 1,500 projects that provide clean water access to more than two million people across 15 countries.

ReGen III: Departure of Gordon Driedger and Promotion of Mark Redcliffe to President

Retrieved on: 
Monday, February 28, 2022
Gordon's Gin, FSE, Negotiation, Regen, BP, Solution, III Corps (United States), LLC, Board, Company, Recycling, ESG, Economics, American Petroleum Institute, KPS, Marketing, CEO, COO, EDC, Sound, Trust, Security (finance), Management, Pharmaceutical industry, Construction

Vancouver, British Columbia--(Newsfile Corp. - February 28, 2022) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company") announces the immediate departure of Mr. Gordon Driedger for personal health reasons.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - February 28, 2022) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company") announces the immediate departure of Mr. Gordon Driedger for personal health reasons.
  • For these reasons I am pleased to announce the immediate promotion of Mark Redcliffe to the position of President.
  • This is a seamless transition for ReGen III and I congratulate Mark on his well-deserved promotion."
  • Mark Redcliffe, President of ReGen III stated, "First, let me thank Gord for his contributions to ReGen III over the past four years.

Dynamic Yield Joins MACH Alliance as Certified Personalization Vendor

Retrieved on: 
Monday, February 28, 2022
Cloud, Dynamic Yield, Motion, Twitter, E-commerce, Personalization, CTO, Alliance, Experience, Acrania, Privacy, Commerce, COVID-19, Organization, Content Guru, Acceleration, MACH, Architecture, API, LinkedIn, New product development, KPS, Technology, ESP, Solution, CMS, Certification, 3D printing, Online shopping

Dynamic Yield's inclusion and certification reflect its ability to offer a flexible, composable, and scalable foundation for personalization.

Key Points: 
  • Dynamic Yield's inclusion and certification reflect its ability to offer a flexible, composable, and scalable foundation for personalization.
  • Representing a natural addition to the MACH Alliance, Dynamic Yield's comprehensive set of Experience APIs are available to deliver faster, cohesive, and data-protected digital experiences on the server-side.
  • "We don't take lightly both the quality and quantity of new members the Alliance continues to bring on," said MACH Alliance president, Sonja Keerl.
  • The MACH Alliance welcomes technology companies and individual industry experts who share the same vision for the future.

Arrowhead Presents New Clinical Data on ARO-HIF2 at ASCO GU 2022

Retrieved on: 
Thursday, February 17, 2022
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, NASDAQ, History, RCC, Society, Patient, Arrowhead, Biomarker, Urine, Cardiomyopathy, Company, Arrowhead Pharmaceuticals, Neoplasm, RECIST, Private Securities Litigation Reform Act, Hypoxia, University of Texas Southwestern Medical Center, RNA, U.S. Securities and Exchange Commission, Gene silencing, KPS, Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., CA, Cohort, Response evaluation criteria in solid tumors, Security (finance), Safety, Performance status, Annual report, Mission statement, Therapy, RNA interference, TKI, Twitter, Chronic inflammatory demyelinating polyneuropathy, Plasma, HIF, Pharmacokinetics, Myocarditis, Serum, Clear cell renal cell carcinoma, Anemia, COVID-19, News, University, Investor, ASCO, Gene, AES, Pharmaceutical industry, Medical imaging

The data are being presented by James Brugarolas, M.D., Ph.D, Professor at University of Texas Southwestern Medical Center and investigator in the study, in a poster presentation at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), being held February 17-19, 2022, in San Francisco, CA and online.

Key Points: 
  • The data are being presented by James Brugarolas, M.D., Ph.D, Professor at University of Texas Southwestern Medical Center and investigator in the study, in a poster presentation at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), being held February 17-19, 2022, in San Francisco, CA and online.
  • AROHIF21001 ( NCT04169711 ) is a Phase 1b dose-finding clinical study in patients with advanced ccRCC to evaluate the safety of ARO-HIF2 and to determine the recommended Phase 2 dose.
  • Secondary objectives include the assessment of pharmacokinetics and preliminary efficacy, based on Response Evaluation Criteria in Solid Tumors (RECIST).
  • Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.